Suppr超能文献

一种内质网和脂滴双定位策略,用于开发在光动力疗法期间诱导铁死亡的小分子光敏剂。

An endoplasmic reticulum and lipid droplets dual-localized strategy to develop small molecular photosensitizers that induce ferroptosis during photodynamic therapy.

作者信息

Kang Ke, Wu You, Zhang Xi, Wang Shuqi, Ni Shaokai, Shao Jiaan, Du Yushen, Yu Yongping, Shen Yong, Chen Yiding, Chen Wenteng

机构信息

College of Pharmaceutical Science, Zhejiang University, Hangzhou, Zhejiang, 310058, China.

College of Pharmaceutical Science, Zhejiang University, Hangzhou, Zhejiang, 310058, China; Jinhua Institute of Zhejiang University, Jinhua, Zhejiang, 321299, China.

出版信息

Eur J Med Chem. 2025 Mar 15;286:117306. doi: 10.1016/j.ejmech.2025.117306. Epub 2025 Jan 21.

Abstract

Organelle-localized photosensitizers have been well-developed to enhance the photodynamic therapy (PDT) efficacy through triggering given cell death. The endoplasmic reticulum (ER) and lipid droplets (LDs) are two key organelles mutually regulating ferroptosis. Thus, in this study, small molecular photosensitizer CAR PSs were developed through fragment integration strategy and the heavy-atom modification. It was showed that the integration strategy did not affect the organelle localization and CAR PSs successfully achieved ER/LDs dual location. Besides, the heavy-atom modification help CAR PSs display good ROS generation efficiency. Importantly, ER/LDs dual-localized CAR PSs exhibited superior photo-toxicity and lower dark-toxicity against multiple breast cancer cell lines than the only ER-targeting Ce6, which further explained the superposition effect of dual organelle targeting. Preliminary studies revealed that CAR PSs induced enhanced ferroptosis via simultaneously triggering the ER stress and lipid peroxidation during PDT. Moreover, CAR-2 demonstrated significant in vivo PDT activity to suppress the tumor growth in 4T1 tumor bearing mice. These findings not only provide a promising photosensitizer CAR-2 exerting excellent in vitro and in vivo PDT effect through stimulating ferroptosis, but also propose a design strategy for the development of ER/LDs dual localized PSs.

摘要

细胞器定位的光敏剂已得到充分发展,可通过引发特定的细胞死亡来提高光动力疗法(PDT)的疗效。内质网(ER)和脂滴(LDs)是相互调节铁死亡的两个关键细胞器。因此,在本研究中,通过片段整合策略和重原子修饰开发了小分子光敏剂CAR PSs。结果表明,整合策略不影响细胞器定位,CAR PSs成功实现了内质网/脂滴双定位。此外,重原子修饰有助于CAR PSs表现出良好的活性氧生成效率。重要的是,内质网/脂滴双定位的CAR PSs对多种乳腺癌细胞系表现出比仅内质网靶向的Ce6更高的光毒性和更低的暗毒性,这进一步解释了双细胞器靶向的叠加效应。初步研究表明,CAR PSs在光动力疗法期间通过同时触发内质网应激和脂质过氧化诱导增强的铁死亡。此外,CAR-2在4T1荷瘤小鼠中表现出显著的体内光动力疗法活性,可抑制肿瘤生长。这些发现不仅提供了一种有前景的光敏剂CAR-2,通过刺激铁死亡发挥优异的体外和体内光动力疗法效果,还提出了一种开发内质网/脂滴双定位光敏剂的设计策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验